Compositions for nasal administration of pharmaceuticals
US7638138B2 · kind B2 · utility
27Cited by
9References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2003 |
| Grant date | Dec 29, 2009 |
| Priority date | — |
| Expiry date | Oct 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/29
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.